Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Onkologie|March 8, 2003
Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopyS Rickes, S Hauptmann, B Flath, et al.Annals of Hematology|December 19, 1998
Transient tetraparesis after intrathecal and high-dose systemic methotrexateG Massenkeil, E Späth-Schwalbe, B Flath, et al.Zeitschrift Fur Gastroenterologie|September 15, 2001
[Pancreatic metastases of renal cell carcinomas - evaluation of the contrast behavior at echo-enhanced power-Doppler sonography in comparison to primary pancreatic tumors]S Rickes, B Flath, K Unkrodt, et al.Investigational New Drugs|December 16, 1998
Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I studyD Lüftner, B Flath, C Akrivakis, et al.Annals of Hematology|June 2, 2000
An unusual case of leukemic non-Hodgkin's lymphoma with blastic transformationE Späth-Schwalbe, B Flath, O Kaufmann, et al.Anti-Cancer Drugs|July 8, 2000
Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I studyK Akrivakis, P Schmid, B Flath, et al.Anti-Cancer Drugs|October 3, 1999
Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancerP Schmid, K Akrivakis, B Flath, et al.Journal of Neuroimmunology|October 7, 2015
Neurocognitive function, brain-derived neurotrophic factor (BDNF) and IL-6 levels in cancer patients with depressionC F Jehn, B Becker, B Flath, et al.Breast Cancer Research and Treatment|November 6, 2012
Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancerC F Jehn, B Flath, A Strux, et al.Anticancer Research|May 1, 2001
A comparison of bone-related biomarkers and CA27.29 to assess response to treatment of osseous metastatic breast cancerD Lüfter, A Richter, S Günther, et al.Pageof 3